Table 2 |
|
| Strength of evidence for biological factors supporting merging in some way schizophrenia, schizoaffective and bipolar I disorder | |
| Biological factor | Strength of evidence |
| Genetics—family studies | Strongest |
| Genetics—twin studies | Moderate |
| Genetics—candidate gene/GWAS | Moderate |
| Brain—morphology | Moderate |
| Pharmacotherapeutics—lithium, divalproex, lamotrigine, antipsychotics | Weak |
GWAS, genome wide association studies.
Cosgrove and Suppes
Cosgrove and Suppes BMC Medicine 2013 11:127 doi:10.1186/1741-7015-11-127
